These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6594243)

  • 21. Lymphatic metastasis of mammary adenocarcinoma. An experimental study in the rat with a brief review of the literature.
    Carr I; Carr J; Dreher B
    Invasion Metastasis; 1981; 1(1):34-53. PubMed ID: 6765247
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor-elicited polymorphonuclear cells, in contrast to "normal" circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells.
    Welch DR; Schissel DJ; Howrey RP; Aeed PA
    Proc Natl Acad Sci U S A; 1989 Aug; 86(15):5859-63. PubMed ID: 2762301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth and histology of four canine mammary tumour lines established in nude mice.
    Thomas SE; Thomas N; Pierrepoint CG
    Eur J Cancer Clin Oncol; 1983 Jul; 19(7):979-87. PubMed ID: 6684053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly metastatic 13762NF rat mammary adenocarcinoma cell clones stimulate bone marrow by secretion of granulocyte-macrophage colony-stimulating factor/interleukin-3 activity.
    McGary CT; Miele ME; Welch DR
    Am J Pathol; 1995 Dec; 147(6):1668-81. PubMed ID: 7495292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonrandom abnormalities involving chromosome 1 and Harvey-ras-1 alleles in rat mammary tumor progression.
    Aldaz CM; Chen A; Gollahon LS; Russo J; Zappler K
    Cancer Res; 1992 Sep; 52(17):4791-8. PubMed ID: 1511443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of cell fusion to analyse factors involved in tumour cell metastasis.
    Ramshaw IA; Carlsen S; Wang HC; Badenoch-Jones P
    Int J Cancer; 1983 Oct; 32(4):471-8. PubMed ID: 6684641
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection of highly metastatic rat MTLn2 mammary adenocarcinoma cell variants using in vitro growth response to transferrin.
    Cavanaugh PG; Nicolson GL
    J Cell Physiol; 1998 Jan; 174(1):48-57. PubMed ID: 9397155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Experimental model for locally recurring mammary tumors. Development, morphology, karyotype, growth kinetics, and experimental metastatic potential.
    Estrada J; Freeman DL; Aeed PA; Welch DR
    Cancer; 1989 Apr; 63(7):1353-62. PubMed ID: 2920363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spontaneous capillary tube migration of metastatic rat mammary adenocarcinoma cells.
    Badenoch-Jones P; Ramshaw IA
    Invasion Metastasis; 1984; 4(2):98-110. PubMed ID: 6539758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of Mts1, a metastasis-associated gene, increases motility but not invasion of a nonmetastatic mouse mammary adenocarcinoma cell line.
    Ford HL; Salim MM; Chakravarty R; Aluiddin V; Zain SB
    Oncogene; 1995 Nov; 11(10):2067-75. PubMed ID: 7478526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in morphology and hormone dependency following transplantation of rat 9,10-Dimethyl-1,2-benzanthracene-induced mammary adenocarcinoma.
    Horn H; Erlichman I; Geier A; Levij IS
    Eur J Cancer (1965); 1976 Mar; 12(3):189-94. PubMed ID: 820559
    [No Abstract]   [Full Text] [Related]  

  • 32. Loss of intercellular junctional communication correlates with metastatic potential in mammary adenocarcinoma cells.
    Nicolson GL; Dulski KM; Trosko JE
    Proc Natl Acad Sci U S A; 1988 Jan; 85(2):473-6. PubMed ID: 3422438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The proportionality of glutaminase content to growth rate and morphology of rat neoplasms.
    Knox WE; Horowitz ML; Friedell GH
    Cancer Res; 1969 Mar; 29(3):669-80. PubMed ID: 5251291
    [No Abstract]   [Full Text] [Related]  

  • 34. Dual secretory and myoepithelial differentiation in the transplantable R3230AC rat mammary carcinoma.
    Papotti M; Coda R; Ottinetti A; Bussolati G
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1988; 55(1):39-45. PubMed ID: 2898832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Malignant myoepithelial cells are associated with the differentiated papillary structure and metastatic ability of a syngeneic murine mammary adenocarcinoma model.
    Bumaschny V; Urtreger A; Diament M; Krasnapolski M; Fiszman G; Klein S; Joffé EB
    Breast Cancer Res; 2004; 6(2):R116-29. PubMed ID: 14979922
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of miltefosine on transplanted methylnitrosourea-induced mammary carcinoma growing in Fischer 344 rats.
    Reinhardt M; Heyl P; Amelung F; Berger MR
    Arzneimittelforschung; 1992 Oct; 42(10):1239-42. PubMed ID: 1282010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-cell-platelet aggregation does not correlate with metastatic potential of rat 13762NF mammary adenocarcinoma tumor cell clones.
    Estrada J; Nicolson GL
    Int J Cancer; 1984 Jul; 34(1):101-5. PubMed ID: 6746111
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenovirus-mediated gene therapy in an experimental model of breast cancer metastatic to the brain.
    Colak A; Goodman JC; Chen SH; Woo SL; Grossman RG; Shine HD
    Hum Gene Ther; 1995 Oct; 6(10):1317-22. PubMed ID: 8590736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of host immune status on the spontaneous metastasis of cloned cell lines of the 13762NF rat mammary adenocarcinoma.
    North SM; Nicolson GL
    Br J Cancer; 1985 Nov; 52(5):747-55. PubMed ID: 4063149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of tumor cells from a single mouse mammary tumor.
    Dexter DL; Kowalski HM; Blazar BA; Fligiel Z; Vogel R; Heppner GH
    Cancer Res; 1978 Oct; 38(10):3174-81. PubMed ID: 210930
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.